Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Yoshiyuki Takahashi"'
Autor:
Hiroyuki Shimada, Akihiko Tanizawa, Takeshi Kondo, Tokiko Nagamura-Inoue, Masahiro Yasui, Arinobu Tojo, Hideki Muramatsu, Tetsuya Eto, Noriko Doki, Masatsugu Tanaka, Maho Sato, Maiko Noguchi, Naoyuki Uchida, Yoshiyuki Takahashi, Naoki Sakata, Tatsuo Ichinohe, Yoshiko Hashii, Koji Kato, Yoshiko Atsuta, Kazuteru Ohashi
Publikováno v:
Transplantation and Cellular Therapy. 28:376-389
The breakthrough effects of tyrosine kinase inhibitors (TKIs) have lessened indications for allogeneic hematopoietic stem cell transplantation (HSCT) in chronic myeloid leukemia (CML). However, HSCT is still attractive for children and adolescents/yo
Autor:
Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken‐ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Yoshiyuki Takahashi, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta, Ayako Arai
Publikováno v:
American Journal of Hematology. 97:780-790
The effects of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on systemic chronic active Epstein-Barr virus infection (sCAEBV) are yet to be analyzed in a large number of patients. Using the Japanese registry database, Transplant Regi
Autor:
Hisashi Ishida, Motohiro Kato, Yuta Kawahara, Sae Ishimaru, Yuho Najima, Shinichi Kako, Maho Sato, Mitsuteru Hiwatari, Maiko Noguchi, Keisuke Kato, Katsuyoshi Koh, Keiko Okada, Fuminori Iwasaki, Ryoji Kobayashi, Shunji Igarashi, Shoji Saito, Yoshiyuki Takahashi, Atsushi Sato, Junji Tanaka, Yoshiko Hashii, Yoshiko Atsuta, Hirotoshi Sakaguchi, Toshihiko Imamura
Publikováno v:
Hematological Oncology. 40:457-468
Acute lymphoblastic leukemia (ALL) is the most common cancer during childhood, and some high-risk patients with ALL require hematopoietic stem cell transplantation (HSCT). Mainly due to small patient numbers, studies focusing specifically on children
Autor:
Ryo Maemura, Manabu Wakamatsu, Kana Matsumoto, Hirotoshi Sakaguchi, Nao Yoshida, Asahito Hama, Taro Yoshida, Shunsuke Miwata, Hironobu Kitazawa, Kotaro Narita, Shinsuke Kataoka, Daisuke Ichikawa, Motoharu Hamada, Rieko Taniguchi, Kyogo Suzuki, Nozomu Kawashima, Eri Nishikawa, Atsushi Narita, Yusuke Okuno, Nobuhiro Nishio, Koji Kato, Seiji Kojima, Kunihiko Morita, Hideki Muramatsu, Yoshiyuki Takahashi
Publikováno v:
Cell transplantation. 31
Melphalan is widely used for hematopoietic stem cell transplantation (HSCT) conditioning. However, the relationship between its pharmacokinetic (PK) and transplantation outcomes in children has not been thoroughly investigated. We prospectively analy
Autor:
Hideki Muramatsu, Yusuke Okuno, Motoharu Hamada, Seiji Kojima, Atsushi Narita, Norihiro Murakami, Mignon L. Loh, Kotaro Narita, Daisuke Ichikawa, Elliot Stieglitz, Manabu Wakamatsu, Hironobu Kitazawa, Asahito Hama, Nozomu Kawashima, Rieko Taniguchi, Kyogo Suzuki, Shinsuke Kataoka, Yoshiyuki Takahashi, Nobuhiro Nishio, Eri Nishikawa, Kosuke Aoki
Publikováno v:
Blood Advances
Blood advances, vol 5, iss 24
Blood advances, vol 5, iss 24
Key Points A total of 137 patients with JMML were analyzed using DREAM.We developed a robust DNA methylation test that is highly consistent with the array-based international consensus definition for JMML.
Visual Abstract
Juvenile myelomono
Visual Abstract
Juvenile myelomono
Autor:
Maho Sato, Tomohiro Morio, Hiromasa Yabe, Akira Nishimura, Koji Kato, Yoshiyuki Takahashi, Masami Inoue, Satoshi Miyamoto, Takashi Koike, Akihiro Iguchi, Kohsuke Imai, Tomonari Shigemura, Yoshiko Atsuta, Yoji Sasahara, Michiko Kajiwara, Masakatsu Yanagimachi, Motohiro Kato, Yoshiko Hashii, Mio Kurata, Masataka Ishimura, Katsutsugu Umeda
Publikováno v:
Journal of Clinical Immunology
Purpose Hematopoietic cell transplantation (HCT) is a curative therapy for patients with severe combined immunodeficiency (SCID). Here, we conducted a nationwide study to assess the outcome of SCID patients after HCT in Japan. Methods A cohort of 181
Autor:
Toshiki Nakane, Tomohiko Nakata, Yu Okai, Hisashi Kawai, Masaharu Tanaka, Hiroyuki Kidokoro, Yoko Sakaguchi, Yoshiyuki Takahashi, Toshiaki Taoka, Jun Natsume, Hiroyuki Yamamoto, Yuji Ito, Hideki Muramatsu, Atsuko Ohno, Shinji Naganawa
Publikováno v:
Pediatric Neurology. 111:78-84
Background Advances in hematopoietic stem cell transplantation have improved the survival rate of malignant diseases and congenital immunodeficiencies. It has become important to assess long-term complications in survivors. To assess neurological abn
Autor:
Masaki Yamamoto, Satoru Miyano, Hideki Muramatsu, Seishi Ogawa, Hitoshi Kanno, Yuki Yuza, Yoji Sasahara, Etsuro Ito, Seiji Kojima, Hiromasa Yabe, Nobuyuki Hyakuna, Shouichi Ohga, Daiichiro Hasegawa, Kenichi Yoshida, Masanori Nishi, Takuya Kamio, Takeo Sarashina, Harumi Kakuda, Akira Ishiguro, Yoshiyuki Takahashi, Kiminori Terui, Tomohiko Sato, Tsutomu Toki, Akie Kobayashi, Masataka Ishimura, Rika Kanezaki, Hidefumi Hiramatsu, Akira Ohara, Miyuki Tanaka, Shinya Sasaki, Ko Kudo, Shun Koyamaishi
Publikováno v:
Bone Marrow Transplantation. 56:1013-1020
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy for the hematologic manifestations of Diamond–Blackfan anemia (DBA). However, data regarding the optimal conditioning regimen for DBA patients are limited. We re
Autor:
Hiroyuki Shimada, Koji Kato, Nao Yoshida, Yoshiko Atsuta, Maho Sato, Hirotoshi Sakaguchi, Yuko Cho, Daisuke Hasegawa, Katsuyoshi Koh, Motohiro Kato, Kenichiro Watanabe, Yoshiko Hashii, Harumi Kakuda, Yoshiyuki Takahashi, Asahito Hama, Maiko Noguchi, Daiichiro Hasegawa, Kiminori Terui, Miharu Yabe, Atsushi Sato
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:902-910
Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for juvenile myelomonocytic leukemia (JMML), but few large studies of HSCT for JMML exist. Using data from the Japan Society for Hematopoietic Cell Transplantation registry
Autor:
Masao Kobayashi, Yuko Cho, Tomohiro Morio, Hiromasa Yabe, Kohsuke Imai, Katsutsugu Umeda, Masami Inoue, Nao Yoshida, Yoshiko Hashii, Michiko Kajiwara, Masakatsu Yanagimachi, Yoshiko Atsuta, Yoshiyuki Takahashi
Publikováno v:
International Journal of Hematology. 111:869-876
The impact of acute and chronic graft-versus-host disease (GVHD) on clinical outcomes was retrospectively analyzed in 960 patients with non-malignant diseases (NMD) who underwent a first allogeneic hematopoietic stem cell transplantation (HSCT). Grad